Kitasamycin

Kitasamycin

Gene therapy
Clinical data
Other names	Turimycin
AHFS/Drugs.com	International Drug Names
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxooxacyclohexadeca-11,13-dien-7-yl]acetaldehyde (non-preferred name)
CAS Number	39405-35-1 Y
PubChem Template:Abbreviation	5282189
ChemSpider	4445382 N
ChEMBL	ChEMBL1909061 N
Chemical and physical data
Formula	C35H59NO13
Molar mass	701.84 g/mol
3D model (JSmol)	Interactive image
SMILES C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O
InChI InChI=1S/C35H59NO13/c1-19-16-23(14-15-37)31(32(44-8)25(39)17-26(40)45-20(2)12-10-9-11-13-24(19)38)49-34-29(41)28(36(6)7)30(21(3)47-34)48-27-18-35(5,43)33(42)22(4)46-27/h9-11,13,15,19-25,27-34,38-39,41-43H,12,14,16-18H2,1-8H3/b10-9+,13-11+/t19-,20-,21-,22+,23+,24+,25-,27+,28-,29-,30-,31+,32+,33+,34+,35-/m1/s1 N Key:XYJOGTQLTFNMQG-KJHBSLKPSA-N N
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Kitasamycin
Articles
Most recent articles on Kitasamycin Most cited articles on Kitasamycin Review articles on Kitasamycin Articles on Kitasamycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Kitasamycin Images of Kitasamycin Photos of Kitasamycin Podcasts & MP3s on Kitasamycin Videos on Kitasamycin
Evidence Based Medicine
Cochrane Collaboration on Kitasamycin Bandolier on Kitasamycin TRIP on Kitasamycin
Clinical Trials
Ongoing Trials on Kitasamycin at Clinical Trials.gov Trial results on Kitasamycin Clinical Trials on Kitasamycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Kitasamycin NICE Guidance on Kitasamycin NHS PRODIGY Guidance FDA on Kitasamycin CDC on Kitasamycin
Books
Books on Kitasamycin
News
Kitasamycin in the news Be alerted to news on Kitasamycin News trends on Kitasamycin
Commentary
Blogs on Kitasamycin
Definitions
Definitions of Kitasamycin
Patient Resources / Community
Patient resources on Kitasamycin Discussion groups on Kitasamycin Patient Handouts on Kitasamycin Directions to Hospitals Treating Kitasamycin Risk calculators and risk factors for Kitasamycin
Healthcare Provider Resources
Symptoms of Kitasamycin Causes & Risk Factors for Kitasamycin Diagnostic studies for Kitasamycin Treatment of Kitasamycin
Continuing Medical Education (CME)
CME Programs on Kitasamycin
International
Kitasamycin en Espanol Kitasamycin en Francais
Business
Kitasamycin in the Marketplace Patents on Kitasamycin
Experimental / Informatics
List of terms related to Kitasamycin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Kitasamycin (INN) is a macrolide antibiotic. It is produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens. There are several generic names of this drug such as- •Kitasamycin (OS: BAN, JAN, USAN) •Kitasamycine (OS: DCF) •C 637 (IS) •Katasamycin (IS) •Leucomycin (IS) •Kitasamycin (PH: JP XV) •Kitasamycin Acetate (OS: JAN) •Leucomycin Acetate (IS) •Kitasamycin Acetate (PH: JP XV) •Kitasamycin Tartrate (OS: JAN) •Leucomycin Tartrate (IS) •Kitasamycin Tartrate (PH: JP XV)

("Kitasamycin." - Drugs.com. N.p., n.d. Web. 05 July 2013.)

Template:Antibiotic-stub